Back to catalog
Single Respiratory

Chonluten dosing guide

Chonluten is a tripeptide bioregulator (Glu-Asp-Gly) from the Khavinson series that specifically targets lung and bronchial tissue. It supports respiratory function, promotes lung tissue regeneration, and protects against age-related decline in pulmonary function.

Quickstart Highlights

  • Dosage: 10-20mg
  • Frequency: Daily for 10-20 days
  • Administration: Oral (capsule) or subcutaneous
  • Cycle length: 10-20 days, repeat 2-3x yearly

How This Works

Chonluten acts as an epigenetic regulator specific to lung and bronchial tissue. It modulates gene expression to restore normal function in pulmonary epithelial cells, supports mucus membrane integrity, and may promote regeneration of damaged lung tissue. It targets age-related and damage-induced changes in respiratory tissue.

Mechanism of Action

How Chonluten Works in Your Body

1

Peptide Administered

Enters the bloodstream via injection

2

Receptor Binding

Finds and activates its target receptor

3

Signal Cascade

Triggers a chain of cellular responses

4

Biological Effect

The body produces the desired outcome

Receptor Binding

How peptides activate cellular receptors

  1. Approach
  2. Bind
  3. Activate

Benefits & Side Effects

Potential Benefits

  • Improved pulmonary function
  • Support for respiratory conditions
  • Lung tissue regeneration
  • Bronchial membrane support
  • Respiratory anti-aging
  • May help post-infection lung recovery

Potential Side Effects

  • Generally very well-tolerated
  • Minimal reported side effects
  • Limited Western clinical data

Good to know

  • Khavinson bioregulator for lung and bronchial tissue.
  • Tripeptide: Glu-Asp-Gly.
  • Targets respiratory epithelium.
  • Short intensive courses (10-20 days).
  • May support COPD, asthma, and age-related lung decline.
  • Often used alongside other respiratory therapies.
  • Oral form available.

Community Insights

Summarised from 2 sources

Chonluten is a tripeptide bioregulator (Glu-Asp-Gly) from the Khavinson series that specifically targets lung and bronchial tissue. It supports respiratory function, promotes lung tissue regeneration, and protects against age-related decline in pulmonary function. Khavinson lung/bronchial bioregulat

Common Dosages Reported

  • 10-20mg Daily for 10-20 days
  • Standard protocol dosing

Side Effects Mentioned

  • Generally mild, individual variation expected
  • See full guide for detailed safety info

Stacking Suggestions

  • Consult research and healthcare provider before stacking

What people are saying

Results vary based on individual response
Consistent dosing and timing important

Reviews & Discussion

Real experiences shared by the community — not medical advice.

Your rating:

Auto-moderated. Not medical advice.

Chonluten for Post-Flu Lung Recovery

A user reported that taking Chonluten helped clear up their lungs following a bout of the flu. They noted that their breathing felt significantly better after using the peptide.

Respiratory Benefits of Chonluten

A user described Chonluten as a powerful respiratory peptide. They highlighted its potential effectiveness for improving lung function and overall respiratory health.

Lung Recovery Support

A user reported using Chonluten to assist with lung recovery after quitting smoking. They noted that the substance has a sulfuric taste similar to aging NAC, but clarified that one typically adjusts to the flavor quickly during administration.

Potential for COPD Treatment

A user expressed interest in using Chonluten to treat COPD, noting they had read promising information regarding its efficacy for pulmonary conditions. Other contributors in the discussion supported the potential benefits of this bioregulator for respiratory issues.

Lung Recovery Post-COVID

A user researched Chonluten as a potential treatment for long-term respiratory irritation and congestion following a COVID-19 infection. The discussion centered on its specialized role as a lung bioregulator designed to support pulmonary tissue repair.

Auto-moderated. Not medical advice.

No discussion yet — be the first.

Auto-moderated. Not medical advice.

No notes yet — be the first.